Arrowstreet Capital’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-105,777
Closed -$1.21M – 2688
2020
Q4
$1.21M Buy
105,777
+74,403
+237% +$848K ﹤0.01% 1765
2020
Q3
$216K Buy
+31,374
New +$206K ﹤0.01% 2189
2018
Q4
– Sell
-20,050
Closed -$434K – 1578
2018
Q3
$434K Buy
+20,050
New +$379K ﹤0.01% 917

Arrowstreet Capital's ARA Position: Q1 2021 in Review

Arrowstreet Capital sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 105,777 shares — an estimated $1.21M sold.

Arrowstreet Capital first reported a position in ARA in Q3 2018 and held it in 3 quarters. The position peaked at $1.21M in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Arrowstreet Capital reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 105,777 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $1.21M.
  • Arrowstreet Capital first reported a position in American Renal Associates Holdings, Inc in Q3 2018 and held it in 3 quarters.
  • Arrowstreet Capital's American Renal Associates Holdings, Inc position peaked at $1.21M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.